Mark Stolper - May 21, 2021 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Director
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Mark Stolper
Stock symbol
CHRS
Transactions as of
May 21, 2021
Transactions value $
$0
Form type
4
Date filed
5/25/2021, 04:56 PM
Previous filing
Jul 2, 2021
Next filing
Sep 24, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRS Stock Option (Right to Buy) Award $0 +20K $0.00 20K May 21, 2021 Common Stock 20K $13.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from May 21, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.